DACARBAZINE

DACARBAZINE was reported 7561 times

DACARBAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD LOSS ANAEMIA NEONATAL 3 0.4286
1 INFUSION SITE JOINT MOVEMENT IMPAIRMENT 4 0.4000
2 BASAL GANGLION DEGENERATION 35 0.3723
3 HODGKIN'S DISEASE RECURRENT 7 0.2917
4 PARAGANGLION NEOPLASM MALIGNANT 8 0.2667
5 SYNOVIAL SARCOMA METASTATIC 4 0.1667
6 NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA 5 0.1613
7 PNEUMONIA SALMONELLA 6 0.1277
8 TISSUE INFILTRATION 36 0.1220
9 PLEUROPARENCHYMAL FIBROELASTOSIS 12 0.1154
10 ASTHENOSPERMIA 7 0.1077
11 HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED 4 0.1053
12 MENINGOENCEPHALITIS AMOEBIC 6 0.1034
13 ENDOCARDITIS NONINFECTIVE 13 0.0872
14 PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0851
15 LEUKOPENIA NEONATAL 5 0.0758
16 MALIGNANT SWEAT GLAND NEOPLASM 4 0.0741
17 ANAESTHESIA 27 0.0740
18 CARDIAC VALVE THICKENING 4 0.0678
19 ACUTE MYELOMONOCYTIC LEUKAEMIA 15 0.0595
20 SPERMATOGENESIS ABNORMAL 5 0.0595
21 AUTOIMMUNE PANCYTOPENIA 5 0.0549
22 PLATELET TOXICITY 5 0.0543
23 LEUKODYSTROPHY 5 0.0538
24 MENINGITIS STREPTOCOCCAL 7 0.0479
25 TOOTH MALFORMATION 8 0.0462
26 TUMOUR OBSTRUCTION 4 0.0460
27 UTERINE ENLARGEMENT 36 0.0453
28 AUTOIMMUNE NEUTROPENIA 13 0.0450
29 TREATMENT RELATED SECONDARY MALIGNANCY 9 0.0443
30 SPINDLE CELL SARCOMA 6 0.0441
31 INFUSION SITE ULCER 4 0.0435
32 ACANTHAMOEBA INFECTION 8 0.0426
33 OOPHORITIS 6 0.0423
34 INFUSION SITE HYPOAESTHESIA 4 0.0421
35 OLIGOSPERMIA 4 0.0388
36 ALEXIA 3 0.0370
37 APOPTOTIC COLONOPATHY 3 0.0361
38 MELANOSIS 4 0.0357
39 CARBON MONOXIDE DIFFUSING CAPACITY DECREASED 6 0.0353
40 ACUTE POLYNEUROPATHY 10 0.0350
41 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 5 0.0347
42 NEUROBLASTOMA RECURRENT 7 0.0345
43 PSYCHOGENIC SEIZURE 32 0.0342
44 HYPOCHROMIC ANAEMIA 34 0.0335
45 DESMOID TUMOUR 7 0.0333
46 MALIGNANT NEOPLASM OF PLEURA 4 0.0325
47 CORONARY OSTIAL STENOSIS 4 0.0317
48 ICHTHYOSIS 8 0.0317
49 THYMUS ENLARGEMENT 5 0.0312
50 PULMONARY TOXICITY 201 0.0284
51 BETA 2 MICROGLOBULIN INCREASED 7 0.0268
52 COLITIS EROSIVE 4 0.0252
53 BULLOUS LUNG DISEASE 3 0.0240
54 GASTROINTESTINAL MUCORMYCOSIS 4 0.0240
55 BILE ACIDS INCREASED 4 0.0226
56 LYMPHOMA TRANSFORMATION 8 0.0222
57 HODGKIN'S DISEASE 16 0.0221
58 BIFASCICULAR BLOCK 4 0.0214
59 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 5 0.0209
60 INFUSION SITE NECROSIS 4 0.0208
61 DISTAL INTESTINAL OBSTRUCTION SYNDROME 7 0.0208
62 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 4 0.0202
63 ALLOGENIC STEM CELL TRANSPLANTATION 3 0.0190
64 PERICARDITIS CONSTRICTIVE 8 0.0190
65 ENTEROBACTER SEPSIS 7 0.0189
66 SECOND PRIMARY MALIGNANCY 156 0.0187
67 AZOOSPERMIA 7 0.0182
68 TUMOUR THROMBOSIS 4 0.0175
69 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 4 0.0174
70 METASTATIC MALIGNANT MELANOMA 39 0.0170
71 VASOGENIC CEREBRAL OEDEMA 12 0.0167
72 ENTEROBACTER BACTERAEMIA 5 0.0165
73 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 5 0.0160
74 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 5 0.0159
75 METASTASES TO THORAX 4 0.0158
76 INVASIVE LOBULAR BREAST CARCINOMA 8 0.0156
77 MYELITIS 24 0.0155
78 BONE SARCOMA 3 0.0155
79 COLONIC OBSTRUCTION 4 0.0153
80 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 9 0.0152
81 PREMATURE MENOPAUSE 14 0.0152
82 GASTROENTERITIS BACTERIAL 5 0.0152
83 PERIPHERAL NERVE INJURY 13 0.0148
84 MICROPHTHALMOS 4 0.0147
85 PERIPHERAL MOTOR NEUROPATHY 20 0.0143
86 METASTASES TO ABDOMINAL CAVITY 7 0.0142
87 NEUROLOGICAL DECOMPENSATION 32 0.0138
88 EJECTION FRACTION 8 0.0138
89 BRONCHOPNEUMOPATHY 5 0.0136
90 PNEUMATOSIS 6 0.0135
91 FEBRILE BONE MARROW APLASIA 56 0.0132
92 VANISHING BILE DUCT SYNDROME 14 0.0126
93 DYSAESTHESIA 38 0.0124
94 ENANTHEMA 7 0.0122
95 ACUTE MYELOID LEUKAEMIA 188 0.0121
96 WOUND INFECTION BACTERIAL 5 0.0120
97 CHLOROMA 5 0.0118
98 PNEUMOTHORAX SPONTANEOUS 8 0.0118
99 ACUTE PROMYELOCYTIC LEUKAEMIA 12 0.0117
100 NEUTROPENIC INFECTION 11 0.0115
101 CARDIOTOXICITY 100 0.0112
102 CEREBRAL MASS EFFECT 4 0.0110
103 ANAL ULCER 9 0.0110
104 NEONATAL HYPOTENSION 4 0.0109
105 DEMYELINATING POLYNEUROPATHY 11 0.0107
106 ILEAL PERFORATION 7 0.0106
107 KLEBSIELLA BACTERAEMIA 10 0.0105
108 LEIOMYOSARCOMA 4 0.0104
109 GENITAL ULCERATION 8 0.0104
110 B PRECURSOR TYPE ACUTE LEUKAEMIA 4 0.0103
111 PRETERM PREMATURE RUPTURE OF MEMBRANES 12 0.0100
112 RETICULOCYTE COUNT INCREASED 8 0.0099
113 FEBRILE NEUTROPENIA 652 0.0098
114 VISCERAL LEISHMANIASIS 7 0.0097
115 PERIPHERAL SENSORIMOTOR NEUROPATHY 12 0.0095
116 PHAEOCHROMOCYTOMA 6 0.0091
117 GROIN INFECTION 5 0.0091
118 SEROSITIS 5 0.0090
119 INFUSION SITE SCAR 4 0.0090
120 METASTASES TO SKIN 9 0.0087
121 PNEUMOCYSTIS JIROVECII PNEUMONIA 86 0.0086
122 FEBRILE INFECTION 10 0.0085
123 ANAEMIA NEONATAL 4 0.0083
124 ELECTROLYTE DEPLETION 4 0.0081
125 HYPERPYREXIA 34 0.0080
126 MYELOID LEUKAEMIA 4 0.0080
127 HYPERCREATININAEMIA 4 0.0080
128 AUTONOMIC NEUROPATHY 8 0.0079
129 ACUTE LYMPHOCYTIC LEUKAEMIA 22 0.0078
130 INTERVERTEBRAL DISC DISORDER 33 0.0077
131 MONOPLEGIA 32 0.0074
132 KLEBSIELLA INFECTION 37 0.0073
133 PNEUMOMEDIASTINUM 13 0.0072
134 PERIPHERAL SENSORY NEUROPATHY 41 0.0070
135 CARDIORENAL SYNDROME 4 0.0070
136 CARDIAC DYSFUNCTION 26 0.0070
137 DRUG EXPOSURE BEFORE PREGNANCY 7 0.0069
138 MENINGITIS ASEPTIC 31 0.0069
139 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 9 0.0068
140 INTESTINAL PSEUDO-OBSTRUCTION 6 0.0068
141 HYPERLEUKOCYTOSIS 6 0.0068
142 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
143 PARATHYROID TUMOUR BENIGN 5 0.0067
144 ABDOMINAL TENDERNESS 33 0.0066
145 OXYGEN CONSUMPTION DECREASED 4 0.0066
146 ANGIOSARCOMA 3 0.0065
147 INGUINAL HERNIA 38 0.0062
148 BARRETT'S OESOPHAGUS 5 0.0062
149 KLEBSIELLA TEST POSITIVE 4 0.0061
150 OPTIC ATROPHY 10 0.0061
151 NON-HODGKIN'S LYMPHOMA 8 0.0061
152 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 4 0.0060
153 NEUTROPHIL COUNT ABNORMAL 17 0.0060
154 SOFT TISSUE INFECTION 11 0.0060
155 INFUSION SITE OEDEMA 5 0.0060
156 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 8 0.0059
157 HAEMATOTOXICITY 56 0.0059
158 MYELODYSPLASTIC SYNDROME 85 0.0059
159 URETERIC OBSTRUCTION 8 0.0059
160 PNEUMOCYSTIS JIROVECII INFECTION 7 0.0059
161 QUADRIPLEGIA 12 0.0058
162 ENCEPHALITIS VIRAL 7 0.0057
163 HYPERVENTILATION 33 0.0057
164 SARCOIDOSIS 27 0.0057
165 CHYLOTHORAX 4 0.0055
166 WHITE MATTER LESION 7 0.0055
167 TOXIC LEUKOENCEPHALOPATHY 4 0.0055
168 RENAL CYST 43 0.0054
169 DISSEMINATED CRYPTOCOCCOSIS 4 0.0053
170 SYSTEMIC CANDIDA 13 0.0052
171 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
172 MYOSITIS 46 0.0051
173 SINUS ARREST 8 0.0051
174 CYTOPENIA 62 0.0051
175 GASTROINTESTINAL PERFORATION 21 0.0050
176 NEOPLASM RECURRENCE 17 0.0050
177 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
178 AORTIC VALVE DISEASE 8 0.0050
179 PSEUDOMONAS TEST POSITIVE 4 0.0049
180 ESCHERICHIA SEPSIS 14 0.0048
181 STEM CELL TRANSPLANT 12 0.0048
182 LEFT VENTRICULAR DYSFUNCTION 32 0.0048
183 CARDIAC FIBRILLATION 7 0.0048
184 CHRONIC MYELOID LEUKAEMIA 22 0.0048
185 GUILLAIN-BARRE SYNDROME 23 0.0048
186 PSEUDOMONAL BACTERAEMIA 4 0.0047
187 BONE MARROW DISORDER 14 0.0046
188 NEUTROPENIC SEPSIS 33 0.0046
189 C-REACTIVE PROTEIN DECREASED 3 0.0046
190 GENITAL HERPES 7 0.0046
191 THERAPY PARTIAL RESPONDER 71 0.0045
192 MITRAL VALVE DISEASE 8 0.0045
193 AREFLEXIA 12 0.0045
194 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 42 0.0044
195 HYPERSENSITIVITY PNEUMONITIS 5 0.0044
196 CEREBRAL TOXOPLASMOSIS 4 0.0043
197 ESCHERICHIA BACTERAEMIA 10 0.0042
198 IMMUNE THROMBOCYTOPENIC PURPURA 12 0.0042
199 PAPILLOMA VIRAL INFECTION 7 0.0042
200 HYPERMETROPIA 4 0.0042
201 VASCULAR PAIN 4 0.0042
202 HEPATORENAL SYNDROME 7 0.0041
203 MUCOSAL INFLAMMATION 107 0.0041
204 SUBCUTANEOUS EMPHYSEMA 4 0.0041
205 DEVICE RELATED THROMBOSIS 4 0.0041
206 COLON ADENOMA 4 0.0041
207 VENTRICULAR HYPOKINESIA 13 0.0040
208 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 5 0.0040
209 SMALL CELL LUNG CANCER 6 0.0040
210 BRONCHITIS BACTERIAL 3 0.0040
211 GASTROINTESTINAL TOXICITY 19 0.0040
212 FOETAL GROWTH RESTRICTION 24 0.0039
213 STAPHYLOCOCCAL BACTERAEMIA 17 0.0039
214 CANDIDA INFECTION 66 0.0039
215 NEUTROPENIA 524 0.0038
216 AUTOIMMUNE HAEMOLYTIC ANAEMIA 13 0.0038
217 PNEUMOPERITONEUM 7 0.0038
218 OTOTOXICITY 7 0.0038
219 GASTROINTESTINAL NECROSIS 11 0.0038
220 JC VIRUS INFECTION 6 0.0037
221 PNEUMONITIS 102 0.0037
222 STENOSIS 7 0.0037
223 HISTIOCYTOSIS HAEMATOPHAGIC 11 0.0037
224 HYPERURICAEMIA 15 0.0036
225 MENINGITIS VIRAL 5 0.0036
226 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 8 0.0036
227 TRAUMATIC LUNG INJURY 7 0.0036
228 ILEUS 45 0.0036
229 CONGESTIVE CARDIOMYOPATHY 15 0.0036
230 POLYNEUROPATHY 43 0.0036
231 APLASIA 7 0.0036
232 SUBCLAVIAN VEIN THROMBOSIS 4 0.0035
233 SMALL INTESTINAL HAEMORRHAGE 7 0.0035
234 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
235 SYSTEMIC MYCOSIS 4 0.0034
236 OSTEOLYSIS 7 0.0034
237 ABDOMINAL NEOPLASM 3 0.0034
238 NEUTROPHIL COUNT DECREASED 137 0.0034
239 ORAL INTAKE REDUCED 8 0.0033
240 CLOSTRIDIUM COLITIS 4 0.0033
241 EMBOLISM VENOUS 10 0.0033
242 SECONDARY IMMUNODEFICIENCY 4 0.0033
243 AMYLASE INCREASED 12 0.0032
244 FIBROSIS 10 0.0032
245 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
246 NEUROPATHY PERIPHERAL 308 0.0032
247 LUNG INFILTRATION 28 0.0032
248 RED BLOOD CELL SEDIMENTATION RATE INCREASED 35 0.0032
249 ILEUS PARALYTIC 14 0.0031
250 INTRA-UTERINE DEATH 5 0.0031
251 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
252 ACUTE LEUKAEMIA 5 0.0031
253 SPLENOMEGALY 36 0.0031
254 SPINAL PAIN 36 0.0031
255 ACQUIRED GENE MUTATION 4 0.0031
256 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 25 0.0030
257 SCLERODERMA 11 0.0030
258 EJECTION FRACTION DECREASED 47 0.0030
259 HYPERTRANSAMINASAEMIA 21 0.0030
260 IGA NEPHROPATHY 5 0.0030
261 VITILIGO 7 0.0030
262 PULMONARY CONGESTION 39 0.0030
263 LEUKAEMIA RECURRENT 5 0.0030
264 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 22 0.0029
265 NEUTROPENIC COLITIS 6 0.0029
266 DERMATITIS EXFOLIATIVE GENERALISED 10 0.0029
267 BLOOD LACTIC ACID INCREASED 15 0.0028
268 INTESTINAL FISTULA 4 0.0028
269 TUMOUR LYSIS SYNDROME 25 0.0028
270 NEUROENDOCRINE TUMOUR 4 0.0028
271 PULMONARY FIBROSIS 54 0.0028
272 ILEAL STENOSIS 5 0.0028
273 TENDERNESS 29 0.0028
274 MUSCLE SPASTICITY 34 0.0028
275 LEUKOPENIA 138 0.0028
276 LYMPHOPENIA 39 0.0028
277 MYELOSUPPRESSION 99 0.0027
278 IMMUNE-MEDIATED LUNG DISEASE 5 0.0027
279 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
280 PANCREATIC ENZYMES INCREASED 4 0.0027
281 INTERSTITIAL LUNG DISEASE 132 0.0027
282 DIFFUSE LARGE B-CELL LYMPHOMA 21 0.0027
283 ENTEROCOLITIS HAEMORRHAGIC 4 0.0027
284 GRANULOCYTE COUNT DECREASED 5 0.0027
285 DISEASE PROGRESSION 318 0.0027
286 GASTROINTESTINAL WALL THICKENING 4 0.0027
287 ENTERITIS 17 0.0027
288 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
289 ISCHAEMIA 12 0.0026
290 CARBON DIOXIDE DECREASED 3 0.0026
291 APHTHOUS STOMATITIS 6 0.0026
292 GRANULOMA 9 0.0026
293 HYPOTHYROIDISM 83 0.0026
294 ENTEROCOLITIS 15 0.0026
295 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
296 CARDIOMYOPATHY 38 0.0026
297 FUNGAEMIA 4 0.0025
298 PNEUMONIA FUNGAL 10 0.0025
299 GENE MUTATION 5 0.0025
300 EMPYEMA 5 0.0025
301 PREMATURE RUPTURE OF MEMBRANES 6 0.0025
302 PANCYTOPENIA 139 0.0025
303 PANNICULITIS 6 0.0025
304 OESOPHAGEAL STENOSIS 7 0.0025
305 CARDIOVASCULAR INSUFFICIENCY 4 0.0025
306 ENCEPHALITIS 17 0.0025
307 CRYPTOCOCCOSIS 4 0.0025
308 COLITIS 93 0.0025
309 NEOPLASM PROGRESSION 85 0.0024
310 EXTRAVASATION 10 0.0024
311 HYPOKINESIA 35 0.0024
312 EMBOLISM 20 0.0024
313 TROPONIN I INCREASED 4 0.0024
314 OLIGOHYDRAMNIOS 8 0.0024
315 METASTASES TO LYMPH NODES 16 0.0024
316 BACTERAEMIA 28 0.0024
317 DEAFNESS BILATERAL 4 0.0024
318 METASTASES TO LUNG 27 0.0023
319 RADIATION PNEUMONITIS 5 0.0023
320 STREPTOCOCCAL INFECTION 13 0.0023
321 ACUTE RESPIRATORY DISTRESS SYNDROME 41 0.0023
322 VENTRICULAR DYSFUNCTION 6 0.0023
323 PAPILLARY THYROID CANCER 4 0.0023
324 HYPOPITUITARISM 4 0.0023
325 PREMATURE BABY 69 0.0023
326 MENINGITIS CRYPTOCOCCAL 4 0.0023
327 ENTEROCOCCAL INFECTION 11 0.0023
328 OBESITY 36 0.0023
329 CYTOMEGALOVIRUS VIRAEMIA 10 0.0022
330 METASTASIS 16 0.0022
331 INTESTINAL PERFORATION 25 0.0022
332 ORGANISING PNEUMONIA 11 0.0022
333 MALIGNANT NEOPLASM PROGRESSION 226 0.0022
334 HEPATITIS B REACTIVATION 7 0.0022
335 HEPATIC STEATOSIS 41 0.0022
336 SINUS NODE DYSFUNCTION 4 0.0022
337 PNEUMONIA KLEBSIELLA 4 0.0022
338 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
339 HEPATOTOXICITY 48 0.0022
340 PNEUMOTHORAX 34 0.0021
341 JAUNDICE NEONATAL 4 0.0021
342 BONE MARROW TRANSPLANT 4 0.0021
343 PNEUMATOSIS INTESTINALIS 6 0.0021
344 MENINGITIS 14 0.0021
345 BLADDER TRANSITIONAL CELL CARCINOMA 3 0.0021
346 SEPTIC SHOCK 91 0.0021
347 LIPASE INCREASED 16 0.0021
348 BK VIRUS INFECTION 7 0.0021
349 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
350 LYMPHADENOPATHY 73 0.0021
351 LYMPHOPROLIFERATIVE DISORDER 6 0.0020
352 BICYTOPENIA 4 0.0020
353 THROMBOCYTOPENIA 226 0.0020
354 ODYNOPHAGIA 12 0.0020
355 BLOOD CULTURE POSITIVE 6 0.0020
356 RESPIRATORY FAILURE 146 0.0020
357 NEUROTOXICITY 35 0.0020
358 HYPOPHYSITIS 4 0.0020
359 JAUNDICE CHOLESTATIC 7 0.0020
360 METASTASES TO PERITONEUM 5 0.0020
361 IMMUNE-MEDIATED HEPATITIS 4 0.0020
362 PREMATURE LABOUR 11 0.0019
363 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
364 CARDIAC VALVE DISEASE 11 0.0019
365 SEPSIS 214 0.0019
366 APLASTIC ANAEMIA 10 0.0019
367 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
368 LUNG OPACITY 5 0.0019
369 AORTIC VALVE INCOMPETENCE 8 0.0019
370 BONE MARROW FAILURE 38 0.0019
371 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
372 MALIGNANT MELANOMA 25 0.0019
373 LYMPHOCYTOSIS 4 0.0019
374 HERPES SIMPLEX 12 0.0018
375 DRUG TOXICITY 25 0.0018
376 SLEEP APNOEA SYNDROME 35 0.0018
377 CERVICAL DYSPLASIA 4 0.0018
378 OESOPHAGITIS 20 0.0018
379 THROMBOSIS IN DEVICE 6 0.0018
380 BRAIN OEDEMA 23 0.0018
381 THYROID NEOPLASM 5 0.0018
382 CYTOMEGALOVIRUS INFECTION REACTIVATION 8 0.0018
383 GRAFT VERSUS HOST DISEASE 13 0.0018
384 LUNG DISORDER 88 0.0018
385 PNEUMOCYSTIS JIROVECI PNEUMONIA 4 0.0018
386 EPIGASTRIC DISCOMFORT 7 0.0018
387 ERYSIPELAS 9 0.0018
388 METASTASES TO SPINE 6 0.0018
389 GASTRIC POLYPS 4 0.0018
390 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
391 SINUS TACHYCARDIA 24 0.0017
392 HEPATITIS FULMINANT 5 0.0017
393 AORTIC VALVE STENOSIS 3 0.0017
394 ATYPICAL PNEUMONIA 5 0.0017
395 MIXED LIVER INJURY 5 0.0017
396 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17 0.0017
397 CARDIAC FAILURE CHRONIC 7 0.0016
398 RENAL CELL CARCINOMA 8 0.0016
399 HEPATIC LESION 7 0.0016
400 VENTRICULAR HYPERTROPHY 4 0.0016
401 CATHETER SITE INFECTION 6 0.0016
402 ABDOMINAL ABSCESS 7 0.0016
403 NON-CARDIAC CHEST PAIN 5 0.0016
404 DERMATOMYOSITIS 4 0.0016
405 TROPONIN INCREASED 12 0.0016
406 TESTICULAR PAIN 5 0.0016
407 ACUTE CORONARY SYNDROME 13 0.0016
408 NEUTROPHIL COUNT INCREASED 16 0.0016
409 METASTASES TO CENTRAL NERVOUS SYSTEM 20 0.0015
410 CARDIOPULMONARY FAILURE 6 0.0015
411 HYPERTRIGLYCERIDAEMIA 9 0.0015
412 ASPERGILLUS INFECTION 10 0.0015
413 ARTERIOSPASM CORONARY 6 0.0015
414 HEPATITIS B 9 0.0015
415 CYSTITIS HAEMORRHAGIC 6 0.0015
416 TRANSAMINASES INCREASED 33 0.0015
417 B-CELL LYMPHOMA 5 0.0015
418 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
419 PLEURITIC PAIN 4 0.0014
420 BLOOD BILIRUBIN INCREASED 39 0.0014
421 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
422 ANGIOPATHY 8 0.0014
423 TYPE I HYPERSENSITIVITY 5 0.0014
424 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
425 PULMONARY TUBERCULOSIS 6 0.0014
426 GRANULOCYTOPENIA 8 0.0014
427 TUMOUR HAEMORRHAGE 4 0.0014
428 FLUID INTAKE REDUCED 7 0.0014
429 ABSCESS INTESTINAL 3 0.0014
430 CORONARY ARTERY STENOSIS 7 0.0014
431 ACUTE HEPATIC FAILURE 19 0.0014
432 ACUTE MYOCARDIAL INFARCTION 41 0.0014
433 CYTOMEGALOVIRUS INFECTION 23 0.0014
434 BONE PAIN 81 0.0014
435 ANAEMIA 262 0.0014
436 ONYCHOMYCOSIS 6 0.0014
437 AGRANULOCYTOSIS 25 0.0013
438 HYPOXIA 47 0.0013
439 DYSCHEZIA 4 0.0013
440 CHEST X-RAY ABNORMAL 4 0.0013
441 INTRACARDIAC THROMBUS 4 0.0013
442 ANAL ABSCESS 7 0.0013
443 PORTAL HYPERTENSION 4 0.0013
444 BRAIN DEATH 4 0.0013
445 OLIGURIA 8 0.0013
446 VENOUS THROMBOSIS 5 0.0013
447 LOW BIRTH WEIGHT BABY 10 0.0013
448 PREMATURE DELIVERY 20 0.0013
449 ORTHOPNOEA 4 0.0013
450 HEPATIC CYTOLYSIS 16 0.0013
451 ACUTE RESPIRATORY FAILURE 24 0.0012
452 IMMUNOSUPPRESSION 11 0.0012
453 CANDIDIASIS 5 0.0012
454 DERMATITIS BULLOUS 9 0.0012
455 STILLBIRTH 6 0.0012
456 SKIN TOXICITY 7 0.0012
457 PERONEAL NERVE PALSY 7 0.0012
458 THROMBOTIC MICROANGIOPATHY 12 0.0012
459 PLATELET COUNT INCREASED 16 0.0012
460 WHITE BLOOD CELL COUNT DECREASED 133 0.0012
461 DISEASE RECURRENCE 58 0.0012
462 METASTASES TO BONE 20 0.0012
463 NEOPLASM 14 0.0012
464 ESCHERICHIA INFECTION 10 0.0012
465 PERICARDIAL EFFUSION 28 0.0012
466 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
467 METABOLIC DISORDER 7 0.0012
468 CYTOLYTIC HEPATITIS 4 0.0012
469 HYPOTONIA 12 0.0012
470 CARDIAC FAILURE ACUTE 8 0.0012
471 POTENTIATING DRUG INTERACTION 4 0.0012
472 CLOSTRIDIAL INFECTION 4 0.0012
473 STAPHYLOCOCCAL INFECTION 39 0.0012
474 TACHYCARDIA 105 0.0012
475 EXPOSURE DURING PREGNANCY 73 0.0012
476 SUDDEN CARDIAC DEATH 4 0.0012
477 LEUKAEMIA 11 0.0012
478 HEPATIC FIBROSIS 4 0.0012
479 HAEMATOMA 30 0.0012
480 FOETAL DEATH 6 0.0012
481 FAILURE TO THRIVE 6 0.0012
482 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
483 GASTROINTESTINAL INFLAMMATION 9 0.0011
484 DRUG-INDUCED LIVER INJURY 36 0.0011
485 PULMONARY FUNCTION TEST DECREASED 5 0.0011
486 VIRAL INFECTION 38 0.0011
487 PYREXIA 394 0.0011
488 ALANINE AMINOTRANSFERASE INCREASED 69 0.0011
489 CARDIOGENIC SHOCK 16 0.0011
490 GINGIVITIS 6 0.0011
491 SUSPECTED OFF LABEL USE 5 0.0011
492 DEVICE RELATED INFECTION 17 0.0011
493 IMMUNE THROMBOCYTOPENIA 5 0.0011
494 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0011
495 PERFORMANCE STATUS DECREASED 5 0.0011
496 APPENDICITIS 10 0.0011
497 ACUTE PULMONARY OEDEMA 6 0.0011
498 ANAPHYLACTIC REACTION 59 0.0011
499 HYPONATRAEMIA 60 0.0011
500 HYPERBILIRUBINAEMIA 11 0.0011
501 CARDIAC TAMPONADE 5 0.0011
502 CHOLESTASIS 20 0.0010
503 ABORTION 3 0.0010
504 CERVIX CARCINOMA 4 0.0010
505 BACTERIAL INFECTION 19 0.0010
506 ENCEPHALOPATHY 25 0.0010
507 STAPHYLOCOCCAL SEPSIS 5 0.0010
508 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
509 INFUSION SITE PAIN 13 0.0010
510 PLEURAL EFFUSION 61 0.0010
511 HEPATIC FAILURE 30 0.0010
512 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
513 STOMATITIS 60 0.0010
514 ORAL CANDIDIASIS 13 0.0010
515 PHLEBITIS 5 0.0010
516 MITRAL VALVE INCOMPETENCE 11 0.0010
517 RESPIRATORY DISORDER 29 0.0010
518 PRODUCT USE IN UNAPPROVED INDICATION 239 0.0010
519 SKIN NECROSIS 5 0.0010
520 LYMPHOCYTE COUNT DECREASED 17 0.0010
521 MYOCARDITIS 11 0.0010
522 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
523 INTESTINAL STENOSIS 4 0.0009
524 ELECTROLYTE IMBALANCE 11 0.0009
525 HEPATIC FUNCTION ABNORMAL 35 0.0009
526 KETOACIDOSIS 7 0.0009
527 FOETAL EXPOSURE DURING PREGNANCY 76 0.0009
528 C-REACTIVE PROTEIN INCREASED 34 0.0009
529 HYPERTHERMIA 7 0.0009
530 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
531 INFLAMMATION 47 0.0009
532 DEEP VEIN THROMBOSIS 59 0.0009
533 HAEMATOCRIT DECREASED 18 0.0009
534 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
535 HYPOCALCAEMIA 17 0.0009
536 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
537 HYPERCALCAEMIA 11 0.0009
538 HYPOTHERMIA 9 0.0009
539 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
540 DISEASE COMPLICATION 4 0.0009
541 HERPES VIRUS INFECTION 5 0.0009
542 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
543 CAESAREAN SECTION 10 0.0009
544 GASTRITIS EROSIVE 4 0.0009
545 METASTASES TO LIVER 15 0.0009
546 INFECTION 123 0.0008
547 PANCREATITIS ACUTE 19 0.0008
548 LUNG INFECTION 13 0.0008
549 ADRENAL INSUFFICIENCY 10 0.0008
550 HYPERGLYCAEMIA 30 0.0008
551 CARDIAC FAILURE 66 0.0008
552 GENERAL PHYSICAL HEALTH DETERIORATION 95 0.0008
553 HEPATOMEGALY 8 0.0008
554 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
555 SMALL FOR DATES BABY 4 0.0008
556 ABDOMINAL PAIN 187 0.0008
557 INFUSION SITE EXTRAVASATION 5 0.0008
558 NEPHROPATHY TOXIC 9 0.0008
559 INTESTINAL OBSTRUCTION 30 0.0008
560 PEMPHIGOID 6 0.0008
561 CHEMOTHERAPY 3 0.0008
562 PHOTOPSIA 5 0.0008
563 MYOCARDIAL ISCHAEMIA 9 0.0008
564 TOXIC ENCEPHALOPATHY 4 0.0008
565 MASS 11 0.0008
566 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
567 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
568 CEREBRAL ISCHAEMIA 4 0.0008
569 HYPOALBUMINAEMIA 6 0.0008
570 HYPOKALAEMIA 35 0.0008
571 ORTHOSTATIC HYPOTENSION 13 0.0007
572 DRUG RESISTANCE 19 0.0007
573 TREATMENT FAILURE 61 0.0007
574 HICCUPS 6 0.0007
575 ISCHAEMIC STROKE 13 0.0007
576 DYSPHAGIA 69 0.0007
577 COAGULOPATHY 12 0.0007
578 AUTOIMMUNE HEPATITIS 5 0.0007
579 NECROSIS 4 0.0007
580 MALNUTRITION 8 0.0007
581 DRUG INTOLERANCE 69 0.0007
582 RIGHT VENTRICULAR FAILURE 5 0.0007
583 OFF LABEL USE 621 0.0007
584 HEPATOCELLULAR INJURY 10 0.0007
585 NEUTROPHILIA 4 0.0007
586 TOXICITY TO VARIOUS AGENTS 118 0.0007
587 NEUROLOGICAL SYMPTOM 4 0.0007
588 DEHYDRATION 93 0.0007
589 TOXIC SKIN ERUPTION 7 0.0007
590 MULTI-ORGAN FAILURE 12 0.0007
591 BLOOD URIC ACID INCREASED 4 0.0007
592 LIVER INJURY 17 0.0007
593 PYELONEPHRITIS 6 0.0007
594 PULMONARY OEDEMA 31 0.0007
595 STRESS CARDIOMYOPATHY 4 0.0007
596 PLATELET COUNT DECREASED 73 0.0007
597 NIGHT SWEATS 22 0.0007
598 BLOOD CREATINE INCREASED 3 0.0007
599 HYPOPHOSPHATAEMIA 5 0.0007
600 RASH MACULO-PAPULAR 15 0.0007
601 IMMUNODEFICIENCY 10 0.0007
602 HAEMORRHAGE INTRACRANIAL 10 0.0007
603 TYPE 1 DIABETES MELLITUS 4 0.0007
604 TACHYPNOEA 9 0.0007
605 ACUTE GRAFT VERSUS HOST DISEASE 3 0.0007
606 RESPIRATORY DISTRESS 18 0.0007
607 PNEUMONIA 211 0.0007
608 SMALL INTESTINAL OBSTRUCTION 8 0.0006
609 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
610 HEPATIC ENCEPHALOPATHY 6 0.0006
611 OSTEONECROSIS 21 0.0006
612 PULMONARY HAEMORRHAGE 5 0.0006
613 ABORTION INDUCED 6 0.0006
614 SWELLING OF EYELID 4 0.0006
615 INFUSION SITE SWELLING 4 0.0006
616 HYPOPHAGIA 16 0.0006
617 SKIN INFECTION 7 0.0006
618 ABORTION SPONTANEOUS 25 0.0006
619 HYPERTHYROIDISM 9 0.0006
620 ATELECTASIS 6 0.0006
621 ANOREXIA 8 0.0006
622 LIVER FUNCTION TEST ABNORMAL 18 0.0006
623 NEURALGIA 15 0.0006
624 SHOCK HAEMORRHAGIC 5 0.0006
625 PULMONARY EMBOLISM 58 0.0006
626 CORONAVIRUS INFECTION 4 0.0006
627 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
628 CHILLS 70 0.0006
629 BRONCHIECTASIS 4 0.0006
630 INFUSION SITE ERYTHEMA 5 0.0006
631 SPEECH DISORDER 31 0.0006
632 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
633 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
634 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
635 STEVENS-JOHNSON SYNDROME 13 0.0006
636 BLOOD CREATININE INCREASED 38 0.0006
637 ANURIA 5 0.0006
638 BLOOD MAGNESIUM DECREASED 5 0.0006
639 PROTEINURIA 11 0.0006
640 DIVERTICULITIS 16 0.0006
641 HYPOMAGNESAEMIA 8 0.0006
642 URINE OUTPUT DECREASED 5 0.0006
643 GROIN PAIN 5 0.0006
644 CARDIOMEGALY 7 0.0006
645 GRIP STRENGTH DECREASED 5 0.0006
646 SLEEP DISORDER 40 0.0006
647 GASTROINTESTINAL INFECTION 5 0.0006
648 FEAR 15 0.0006
649 NEOPLASM MALIGNANT 37 0.0006
650 HAEMATEMESIS 14 0.0006
651 PELVIC PAIN 10 0.0005
652 LIVER DISORDER 24 0.0005
653 HYPERTENSIVE CRISIS 6 0.0005
654 COLON CANCER 8 0.0005
655 CELLULITIS 27 0.0005
656 NEPHROPATHY 5 0.0005
657 GASTRITIS 14 0.0005
658 STATUS EPILEPTICUS 6 0.0005
659 CEREBRAL HAEMORRHAGE 19 0.0005
660 VOMITING 247 0.0005
661 HERPES ZOSTER 30 0.0005
662 SINUS BRADYCARDIA 5 0.0005
663 HAEMOGLOBIN DECREASED 53 0.0005
664 NERVOUS SYSTEM DISORDER 16 0.0005
665 LIVER FUNCTION TEST INCREASED 11 0.0005
666 CARDIOVASCULAR DISORDER 13 0.0005
667 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
668 COVID-19 PNEUMONIA 6 0.0005
669 HEPATITIS 13 0.0005
670 ATAXIA 6 0.0005
671 CHOLECYSTITIS 6 0.0005
672 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
673 SENSORY DISTURBANCE 8 0.0005
674 BLOOD TEST ABNORMAL 7 0.0005
675 SKIN REACTION 7 0.0005
676 MUSCLE DISORDER 4 0.0005
677 BODY TEMPERATURE INCREASED 10 0.0005
678 VENTRICULAR TACHYCARDIA 8 0.0005
679 ATRIAL FIBRILLATION 47 0.0005
680 BLOOD SODIUM DECREASED 9 0.0005
681 CONSTIPATION 104 0.0005
682 FACIAL PARALYSIS 4 0.0005
683 GASTROINTESTINAL DISORDER 42 0.0005
684 HYPOTENSION 94 0.0005
685 PSEUDOMONAS INFECTION 4 0.0005
686 RESPIRATORY TRACT INFECTION 12 0.0005
687 LOSS OF CONSCIOUSNESS 59 0.0005
688 ACUTE KIDNEY INJURY 70 0.0005
689 THYROID DISORDER 7 0.0005
690 LYMPHOMA 7 0.0005
691 MYALGIA 77 0.0005
692 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
693 RESPIRATORY RATE INCREASED 4 0.0005
694 MATERNAL EXPOSURE DURING PREGNANCY 40 0.0004
695 BASAL CELL CARCINOMA 7 0.0004
696 HAEMOLYTIC ANAEMIA 4 0.0004
697 ASCITES 13 0.0004
698 LEUKOCYTOSIS 8 0.0004
699 DEVICE MALFUNCTION 31 0.0004
700 ABDOMINAL PAIN LOWER 11 0.0004
701 HYPOAESTHESIA 65 0.0004
702 UROSEPSIS 4 0.0004
703 BLOOD POTASSIUM DECREASED 13 0.0004
704 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
705 LACTIC ACIDOSIS 14 0.0004
706 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
707 HYPERHIDROSIS 55 0.0004
708 BLINDNESS UNILATERAL 6 0.0004
709 ARTERIOSCLEROSIS 4 0.0004
710 PAIN IN JAW 12 0.0004
711 DIALYSIS 6 0.0004
712 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
713 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
714 BLINDNESS 17 0.0004
715 FLUID OVERLOAD 6 0.0004
716 EAR PAIN 8 0.0004
717 GASTROENTERITIS 6 0.0004
718 NO THERAPEUTIC RESPONSE 5 0.0004
719 DRUG INTERACTION 65 0.0004
720 DRUG ABUSE 34 0.0004
721 RENAL TUBULAR NECROSIS 4 0.0004
722 DERMATITIS ALLERGIC 5 0.0004
723 CHEST PAIN 73 0.0004
724 TOOTH ABSCESS 4 0.0004
725 MOTOR DYSFUNCTION 4 0.0004
726 INFUSION RELATED REACTION 26 0.0004
727 VISUAL ACUITY REDUCED 13 0.0004
728 SHOCK 9 0.0004
729 SYNCOPE 39 0.0004
730 URINARY RETENTION 13 0.0004
731 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
732 ANAPHYLACTIC SHOCK 10 0.0004
733 MUSCULOSKELETAL CHEST PAIN 6 0.0004
734 ANGINA PECTORIS 11 0.0004
735 DERMATITIS 8 0.0004
736 IMMUNE SYSTEM DISORDER 5 0.0004
737 PANCREATITIS 20 0.0004
738 THERAPY NON-RESPONDER 17 0.0004
739 BLOOD ALBUMIN DECREASED 3 0.0004
740 RENAL FAILURE ACUTE 16 0.0004
741 ABSCESS 6 0.0004
742 JAUNDICE 10 0.0004
743 BACK PAIN 86 0.0004
744 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
745 COUGH 103 0.0004
746 NAUSEA 288 0.0004
747 GASTROINTESTINAL PAIN 4 0.0004
748 PHOTOSENSITIVITY REACTION 6 0.0004
749 PRODUCT USE ISSUE 68 0.0004
750 DIARRHOEA 233 0.0004
751 NERVE INJURY 4 0.0004
752 ATRIAL SEPTAL DEFECT 3 0.0004
753 DYSURIA 13 0.0004
754 CARDIAC ARREST 29 0.0004
755 PREGNANCY 7 0.0003
756 SUBDURAL HAEMATOMA 5 0.0003
757 CARDIAC FAILURE CONGESTIVE 28 0.0003
758 RENAL IMPAIRMENT 29 0.0003
759 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
760 DYSPNOEA 195 0.0003
761 METABOLIC ACIDOSIS 11 0.0003
762 DRUG ERUPTION 6 0.0003
763 HEPATIC ENZYME INCREASED 23 0.0003
764 PULMONARY MASS 5 0.0003
765 MYOCLONUS 4 0.0003
766 URINARY TRACT INFECTION 57 0.0003
767 DIABETIC KETOACIDOSIS 8 0.0003
768 HEPATITIS C 4 0.0003
769 APHASIA 10 0.0003
770 CORONARY ARTERY DISEASE 10 0.0003
771 FUNGAL INFECTION 11 0.0003
772 SKIN LESION 9 0.0003
773 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
774 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
775 PHARYNGITIS 4 0.0003
776 HAIR COLOUR CHANGES 4 0.0003
777 OXYGEN SATURATION DECREASED 18 0.0003
778 OEDEMA PERIPHERAL 39 0.0003
779 HEAD INJURY 10 0.0003
780 ULCER 5 0.0003
781 TREMOR 52 0.0003
782 LETHARGY 18 0.0003
783 ERECTILE DYSFUNCTION 8 0.0003
784 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
785 AUTOIMMUNE DISORDER 3 0.0003
786 TOOTH INFECTION 4 0.0003
787 SARS-COV-2 TEST POSITIVE 4 0.0003
788 BRAIN INJURY 3 0.0003
789 BLOOD UREA INCREASED 5 0.0003
790 QUALITY OF LIFE DECREASED 4 0.0003
791 DECREASED APPETITE 69 0.0003
792 PRODUCT ADMINISTRATION ERROR 6 0.0003
793 SINUS CONGESTION 4 0.0003
794 THROAT TIGHTNESS 8 0.0003
795 UVEITIS 4 0.0003
796 HAEMATURIA 10 0.0003
797 CORONARY ARTERY OCCLUSION 4 0.0003
798 DELIRIUM 10 0.0003
799 MENTAL STATUS CHANGES 8 0.0003
800 PULMONARY HYPERTENSION 6 0.0003
801 PRESYNCOPE 7 0.0003
802 HYPERKALAEMIA 10 0.0003
803 OSTEONECROSIS OF JAW 7 0.0003
804 PNEUMONIA ASPIRATION 7 0.0003
805 RED BLOOD CELL COUNT DECREASED 8 0.0003
806 CONVULSION 16 0.0003
807 COVID-19 49 0.0003
808 ANOSMIA 4 0.0003
809 PRODUCT PRESCRIBING ISSUE 6 0.0003
810 APATHY 4 0.0003
811 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
812 RENAL FAILURE 36 0.0003
813 CONJUNCTIVITIS 5 0.0003
814 ASTHENIA 101 0.0003
815 DYSPNOEA EXERTIONAL 10 0.0003
816 SEIZURE 30 0.0003
817 DRUG INEFFECTIVE 342 0.0003
818 FEMUR FRACTURE 8 0.0003
819 ORAL HERPES 5 0.0003
820 ARRHYTHMIA 12 0.0003
821 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
822 DISORIENTATION 10 0.0003
823 COMA 12 0.0003
824 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
825 HYPERTENSION 53 0.0002
826 THERAPEUTIC RESPONSE DECREASED 15 0.0002
827 CONDITION AGGRAVATED 75 0.0002
828 FEEDING DISORDER 5 0.0002
829 FATIGUE 191 0.0002
830 LUNG NEOPLASM MALIGNANT 10 0.0002
831 BLOOD PRESSURE DECREASED 16 0.0002
832 SKIN DISORDER 8 0.0002
833 NEPHROLITHIASIS 11 0.0002
834 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
835 MOUTH ULCERATION 5 0.0002
836 FACE OEDEMA 4 0.0002
837 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
838 CONFUSIONAL STATE 37 0.0002
839 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
840 EMOTIONAL DISORDER 7 0.0002
841 FALL 75 0.0002
842 ORAL PAIN 5 0.0002
843 DYSPHONIA 13 0.0002
844 OSTEOMYELITIS 4 0.0002
845 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
846 CHEST DISCOMFORT 22 0.0002
847 NECK PAIN 12 0.0002
848 PAIN IN EXTREMITY 63 0.0002
849 ARTHRALGIA 88 0.0002
850 ABDOMINAL DISTENSION 22 0.0002
851 RASH ERYTHEMATOUS 10 0.0002
852 ALOPECIA 41 0.0002
853 RASH 91 0.0002
854 PARAESTHESIA 32 0.0002
855 THROMBOSIS 16 0.0002
856 MEDICATION ERROR 11 0.0002
857 GASTRIC CANCER 5 0.0002
858 EPILEPSY 6 0.0002
859 INFLUENZA LIKE ILLNESS 16 0.0002
860 DEATH 165 0.0002
861 MUSCULOSKELETAL PAIN 10 0.0002
862 WEIGHT DECREASED 53 0.0002
863 IMPAIRED WORK ABILITY 4 0.0002
864 MOVEMENT DISORDER 6 0.0002
865 DISTURBANCE IN ATTENTION 10 0.0002
866 BLOOD POTASSIUM INCREASED 3 0.0002
867 RASH PRURITIC 10 0.0002
868 ADVERSE EVENT 17 0.0002
869 VAGINAL HAEMORRHAGE 8 0.0002
870 DIABETES MELLITUS 14 0.0002
871 CARDIAC DISORDER 17 0.0002
872 PALPITATIONS 21 0.0002
873 HAEMOPTYSIS 5 0.0002
874 SOMNOLENCE 36 0.0002
875 RASH PAPULAR 4 0.0002
876 ARTHRITIS 14 0.0002
877 CHROMATURIA 4 0.0002
878 DIZZINESS 87 0.0002
879 PAIN 107 0.0002
880 AMENORRHOEA 3 0.0002
881 MALAISE 75 0.0002
882 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
883 ABDOMINAL PAIN UPPER 35 0.0002
884 URINARY INCONTINENCE 5 0.0002
885 PRODUCTIVE COUGH 8 0.0002
886 AGITATION 12 0.0002
887 HEART RATE INCREASED 16 0.0002
888 BLISTER 9 0.0002
889 DYSARTHRIA 6 0.0002
890 BURNING SENSATION 11 0.0002
891 UNRESPONSIVE TO STIMULI 4 0.0002
892 SKIN ULCER 4 0.0002
893 RASH GENERALISED 4 0.0002
894 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
895 RENAL DISORDER 7 0.0002
896 BREAST CANCER FEMALE 4 0.0001
897 MUSCULAR WEAKNESS 17 0.0001
898 EMOTIONAL DISTRESS 18 0.0001
899 HEADACHE 93 0.0001
900 EPISTAXIS 11 0.0001
901 PALLOR 4 0.0001
902 FEELING HOT 9 0.0001
903 TREATMENT NONCOMPLIANCE 8 0.0001
904 CHRONIC KIDNEY DISEASE 11 0.0001
905 CARDIO-RESPIRATORY ARREST 6 0.0001
906 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
907 RECTAL HAEMORRHAGE 6 0.0001
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
909 AMNESIA 9 0.0001
910 MENTAL DISORDER 6 0.0001
911 ACCIDENTAL OVERDOSE 5 0.0001
912 COLITIS ULCERATIVE 6 0.0001
913 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
914 DYSPEPSIA 13 0.0001
915 TINNITUS 6 0.0001
916 HYPERSENSITIVITY 24 0.0001
917 ERYTHEMA 26 0.0001
918 CYSTITIS 4 0.0001
919 HYPOGLYCAEMIA 6 0.0001
920 IMPAIRED HEALING 4 0.0001
921 BRONCHITIS 9 0.0001
922 ABASIA 3 0.0001
923 OROPHARYNGEAL PAIN 11 0.0001
924 SKIN EXFOLIATION 10 0.0001
925 ECZEMA 6 0.0001
926 MYOCARDIAL INFARCTION 20 0.0001
927 OEDEMA 6 0.0001
928 SKIN DISCOLOURATION 5 0.0001
929 HAEMATOCHEZIA 6 0.0001
930 SINUSITIS 11 0.0001
931 COGNITIVE DISORDER 5 0.0001
932 UNEVALUABLE EVENT 8 0.0001
933 URTICARIA 17 0.0001
934 WHEEZING 6 0.0001
935 ABNORMAL BEHAVIOUR 4 0.0001
936 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
937 INFLUENZA 11 0.0001
938 PRURITUS 37 0.0001
939 SWELLING 9 0.0001
940 HAEMORRHAGE 10 0.0001
941 ROAD TRAFFIC ACCIDENT 4 0.0001
942 MIGRAINE 9 0.0001
943 BRADYCARDIA 5 0.0001
944 DYSGEUSIA 7 0.0001
945 GAIT DISTURBANCE 18 0.0001
946 MUSCLE SPASMS 17 0.0001
947 FLATULENCE 5 0.0001
948 BREAST CANCER 8 0.0001
949 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
950 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
951 VERTIGO 5 0.0001
952 OVERDOSE 17 0.0001
953 ILLNESS 8 0.0001
954 BLOOD GLUCOSE INCREASED 14 0.0001
955 VISION BLURRED 10 0.0001
956 WEIGHT INCREASED 16 0.0001
957 EYE PAIN 4 0.0001
958 ANGIOEDEMA 3 0.0001
959 DISCOMFORT 4 0.0001
960 PERIPHERAL SWELLING 10 0.0001
961 ANXIETY 18 0.0001
962 SWELLING FACE 4 0.0001
963 BLOOD PRESSURE INCREASED 9 0.0001
964 JOINT SWELLING 7 0.0001
965 MUSCULOSKELETAL STIFFNESS 5 0.0001
966 UNDERDOSE 4 0.0001
967 SUICIDAL IDEATION 5 0.0001
968 CEREBROVASCULAR ACCIDENT 9 0.0001
969 HALLUCINATION 4 0.0001
970 ACNE 4 0.0001
971 INSOMNIA 14 0.0001
972 NASOPHARYNGITIS 9 0.0000
973 DEPRESSION 11 0.0000
974 VISUAL IMPAIRMENT 5 0.0000
975 HOSPITALISATION 6 0.0000
976 DRY SKIN 5 0.0000
977 MEMORY IMPAIRMENT 5 0.0000
978 BALANCE DISORDER 3 0.0000
979 ADVERSE DRUG REACTION 3 0.0000
980 NO ADVERSE EVENT 6 0.0000
981 INJECTION SITE ERYTHEMA 4 0.0000
982 PRODUCT QUALITY ISSUE 4 0.0000
983 FEELING ABNORMAL 7 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
985 ABDOMINAL DISCOMFORT 3 0.0000
986 PRODUCT DOSE OMISSION ISSUE 5 0.0000
987 INJECTION SITE PAIN 5 0.0000